Content Related to Dost Ongur

McLean Hospital Launches Clinical Trial of Ketogenic Therapy for Bipolar Disorder

Baszucki Group announced the launch of a new partnership with McLean Hospital for a clinical trial of a therapeutic ketogenic diet for bipolar disorder. A cross-disciplinary team at the McLean OnTrack™ program will investigate nutritional ketosis as both a novel treatment strategy and a critical...

In the Media: Patients Say Keto Helps With Their Mental Illness. Science Is Racing To Understand Why

Drs. Christopher M. Palmer and Dost Öngür explore the association between psychiatric conditions and metabolic problems.

Experts Share the Latest Advances in Suicide Care

On October 25, McLean Hospital’s Education Outreach Department once again collaborated with Stanford University School of Medicine’s Department of Psychiatry and Behavioral Sciences to host a suicide-focused assessment and treatment course for health care professionals. This free online workshop...

In the Media: Some Psychiatrists Have Started Prescribing Ozempic

Dr. Dost Öngür comments on mental health providers suggesting patients use diabetes medications to counteract the weight gain associated with antipsychotic medications.

In the Media: Report About Maine Gunman Raises Question – Does Hearing Loss Play a Role in Psychosis?

Dr. Dost Öngür comments on the relationship between hearing loss and psychosis.

In the Media: U.S. Psychiatrists Prescribe Wegovy to Battle Medication-Induced Weight Gain

Dr. Dost Öngür reacts to the trend of prescribing new weight-loss drugs to patients who gain weight from psychiatric medications.

Video: Lecture – Glutamate and GABA Mechanisms in Psychosis: Research and Clinical Implications

Presented by Dost Ӧngür, MD, PhD , and W. Brad Ruzicka, MD, PhD , McLean Hospital – Crossroads in Psychiatry lecture

In the Media: CDC Adds Mental Health Disorders to List of Conditions Linked To Higher Risk of Severe COVID-19

Dr. Dost Öngür discusses the CDC’s decision to add mood disorders to the list of conditions that put people at high risk for COVID-19.

In the Media: The Ripple Effects of the COVID-19 Pandemic on Mental Health With Dr. Dost Öngür

Listen to Dr. Dost Öngür discuss the COVID-19 pandemic’s lasting mental health impact on society.

State-of-the-Art Analysis Aims to Improve Early Detection of Psychosis

Early detection has always been the watchword in the treatment of medical conditions. A multidisciplinary team of researchers led by Dost Öngür, MD, PhD , chief of the Division of Psychotic Disorders at McLean Hospital, aims to extend that to the diagnosis and treatment of psychosis. Fueled by a...

In the Media: In It Together – Episode 9/22/20

Dr. Dost Öngür reports on the increase in involuntary psychiatric admissions to hospitals.

In the Media: Signs and Symptoms of Schizoaffective Bipolar Disorder and How to Treat It

Dost Öngür, MD, PhD, and other experts examine the symptoms, diagnosis, and treatment of schizoaffective bipolar disorder.

Video: Dr. Dost Öngür and Oprah Winfrey Talk Schizophrenia

Oprah invited Dr. Dost Öngür to talk about schizophrenia as part of a discussion of Hidden Valley Road, the latest book in Oprah’s Book Club. Watch their talk on demand. What Is Schizophrenia Schizophrenia is a chronic and severe mental health disorder that affects how a person thinks, feels, and...

Collaborations Help the LEAP Center Study Early Psychosis

“Severe mental illnesses are common, they cause a lot of impairment, and available treatments are only partially effective and have many side effects,” said Dost Öngür, MD, PhD , director of McLean’s Laboratory for Early Psychosis (LEAP) Center. “One of the best promises for improving on this...

Peer Counseling’s Critical Role in Psychosis Treatment

If a journey of a thousand miles begins with a step, what is better than having someone along with whom to share it? That is the philosophy behind the peer counseling program at McLean Hospital’s Division of Psychotic Disorders . “A lot of people with these conditions have difficulty working outside...

Big Data Study Identifies Drugs That Increase Risk of Psychosis in Youth With ADHD

Certain drugs prescribed to teens and young adults with ADHD increase their risk of psychosis , say researchers at McLean Hospital and Harvard Medical School. Approximately 5 million individuals in the U.S. under the age of 25 are prescribed these drugs for the treatment of ADHD. The researchers...

Video: Lecture – From Neuroscience to Novel Treatments for Psychosis

Presented by Bruce M. Cohen, MD, PhD , and Dost Öngür, MD, PhD , McLean Hospital – Crossroads in Psychiatry lecture Psychotic disorders are affected by many interacting factors. In fact, large-scale studies conducted on tens of thousands of people with genetic disorders have shown that genetic...

In Vitro Cell Culture Findings Could Lead to Novel Interventions for Schizophrenia

A study recently published in Translational Psychiatry , a Nature journal, has shown how using cultured cells from patients with psychotic disorders, such as schizophrenia , to investigate abnormalities in nerve connections in the brain could lead to new treatments. Strong correlations were observed...

Dost Öngür Named William P. and Henry B. Test Professor of Psychiatry

Dost Öngür, MD, PhD , has been promoted to the rank of full professor at Harvard Medical School (HMS) and has also been selected to serve as the William P. and Henry B. Test Professor of Psychiatry. Dr. Öngür’s impressive and substantial contributions to psychiatric knowledge, to McLean Hospital...

Family Funds Space for Young Patients to Gather and Heal

Andrew Smith was an avid sports fan. Always a contrarian, he rooted for the team his family wasn’t supporting. He had a quirky sense of humor, loved chatting on the phone, and taking long walks, often stopping for pizza. When he died in 2011 at age 30, after struggling for years with schizophrenia...

Dost Ongur Related Content

Type of Content